亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

蘇州麥輪生物科技有限公司  

食品添加劑、膳食補充原料、保健品原料

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:王
  • 電話:0512-66706057-8005
  • 郵件:maggie@mylandpharm.com
  • 微信:18656033903
  • QQ:1677088563
站內(nèi)搜索
 
榮譽資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
亞精胺
單價 1.00 / 千克對比
銷量 暫無
發(fā)貨 江蘇蘇州市付款后3天內(nèi)
庫存 100千克起訂1千克
過期 長期有效
更新 2024-01-31 15:06
 
詳細(xì)信息
中文名稱:亞精胺
中文別名:N-(3-氨基丙基)-1,4-丁二胺
英文名稱:Spermidine
英文別名:N-(3-Aminopropyl)-1,4-butanediamine; Spermidine N-(3-Aminopropyl)-1,4-butanediamine; 4-azaoctamethylenediamine; N-(3-Aminopropyl)-1,4-diaminobutane~1,8-Diamino-4-azaoctane; N-(3-Aminopropyl)-1,4-butandiamine; N-(3-aminopropyl)butane-1,4-diamine; N-(3-ammoniopropyl)butane-1,4-diaminium
CAS號:124-20-9
分子式:C7H22N3
分子量:148.268
含量:98%
外觀:無色透明液體
包裝:1公斤/瓶
用途:膳食補充原料
©2025 蘇州麥輪生物科技有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:7283  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |